Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "IDA"

1939 News Found

Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr
News | July 28, 2021

Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr

The company posted net profit of Rs.321 crores for the period ended June 30, 2020.


Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr
News | July 28, 2021

Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr

The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.


Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
News | July 28, 2021

Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr

The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.


Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22
News | July 26, 2021

Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22

It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.


Gland Pharma Q1FY22 consolidated PAT rises to Rs. 350.65 Cr
News | July 22, 2021

Gland Pharma Q1FY22 consolidated PAT rises to Rs. 350.65 Cr

The company reported total income of Rs.1215.73 crores during the period ended June 30, 2021.


Kwality Pharmaceuticals Q4FY21 consolidated PAT higher at Rs. 8.14 Cr
News | July 04, 2021

Kwality Pharmaceuticals Q4FY21 consolidated PAT higher at Rs. 8.14 Cr

The company reported total income of Rs.263.60 crores during the 12 months period ended March 31, 2021


Medicamen Biotech posts Rs. 3.64 Cr consolidated PAT in Q4FY21
News | June 27, 2021

Medicamen Biotech posts Rs. 3.64 Cr consolidated PAT in Q4FY21

The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021


Jubilant Pharmova posts Q4FY21 consolidated PAT of Rs. 213.90 Cr
News | June 05, 2021

Jubilant Pharmova posts Q4FY21 consolidated PAT of Rs. 213.90 Cr

The company is doubling its chemistry research capacity that should commission by Q2'FY22


Panacea Biotec posts consolidated Q4FY21 loss of Rs. 54.14 crore
News | June 03, 2021

Panacea Biotec posts consolidated Q4FY21 loss of Rs. 54.14 crore

The company reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021


Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr
News | June 01, 2021

Shilpa Medicare Q4FY21 consolidated PAT at Rs. 7.82 Cr

The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021